Clinicians gathered in Houston, Texas, to examine how newer drug options are reshaping cardiometabolic care and how ...
Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results